Astermark J - Search Results

1

F8 haplotype and inhibitor risk: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort.

Schwarz J, Astermark J, Menius ED, Carrington M, Donfield SM, Gomperts ED, Nelson GW, Oldenburg J, Pavlova A, Shapiro AD, Winkler CA, Berntorp E; Hemophilia Inhibitor Genetics Study Combined Cohort. Schwarz J, et al. Among authors: astermark j. Haemophilia. 2013 Jan;19(1):113-8. doi: 10.1111/hae.12004. Epub 2012 Sep 7. Haemophilia. 2013. PMID: 22958194 Free PMC article.

2

No effect of a new second-generation B-domain-deleted recombinant product on lymphocyte transformation in vitro: a study of plasma-derived and recombinant products.

Astermark J, Ekman M, Berntorp E. Astermark J, et al. Br J Haematol. 1997 Nov;99(2):289-94. doi: 10.1046/j.1365-2141.1997.4153222.x. Br J Haematol. 1997. PMID: 9375741 Free article.

3

[Hemophiliacs with HIV. Slower progression of the infection among younger patients and at higher dosages of factor concentrates].

Astermark J, Berntorp E, Stigendal L, Johnsson H. Astermark J, et al. Lakartidningen. 1998 Jan 7;95(1-2):48-50. Lakartidningen. 1998. PMID: 9458646 Swedish.

4

The Malmö-Klaipeda WFH twinning programme: a comparative description of the haemophilia cohorts.

Berntorp E, Astermark J, Jurgutis R, Lethagen S, Petersson C. Berntorp E, et al. Among authors: astermark j. Haemophilia. 1998 Mar;4(2):79-82. doi: 10.1046/j.1365-2516.1998.00169.x. Haemophilia. 1998. PMID: 9873842 Clinical Trial.

5

Malmö International Brother Study (MIBS): an international survey of brother pairs with haemophilia.

Astermark J, Berntorp E. Astermark J, et al. Vox Sang. 1999;77 Suppl 1:80-2. doi: 10.1159/000056723. Vox Sang. 1999. PMID: 10529695

6

The Malmö model for immune tolerance induction: impact of previous treatment on outcome.

Carlborg E, Astermark J, Lethagen S, Ljung R, Berntorp E. Carlborg E, et al. Among authors: astermark j. Haemophilia. 2000 Nov;6(6):639-42. doi: 10.1046/j.1365-2516.2000.00436.x. Haemophilia. 2000. PMID: 11122389

7

Immune tolerance induction and the treatment of hemophilia. Malmö protocol update.

Berntorp E, Astermark J, Carlborg E. Berntorp E, et al. Among authors: astermark j. Haematologica. 2000 Oct;85(10 Suppl):48-50; discussion 50-1. Haematologica. 2000. PMID: 11187871

8

Anti- and procoagulant activities in factor VII-deficient subjects.

Astermark J, Tengborn L, Hedner U, Berntorp E. Astermark J, et al. Thromb Res. 2001 Mar 15;101(6):435-40. doi: 10.1016/s0049-3848(00)00410-2. Thromb Res. 2001. PMID: 11323000

9

The Malmö International Brother Study (MIBS): further support for genetic predisposition to inhibitor development in hemophilia patients.

Astermark J, Berntorp E, White GC, Kroner BL; MIBS Study Group. Astermark J, et al. Haemophilia. 2001 May;7(3):267-72. doi: 10.1046/j.1365-2516.2001.00510.x. Haemophilia. 2001. PMID: 11380630

10

Antibodies to factor VIIa in patients with haemophilia and high-responding inhibitors.

Astermark J, Ekman M, Berntorp E. Astermark J, et al. Br J Haematol. 2002 Nov;119(2):342-7. doi: 10.1046/j.1365-2141.2002.03853.x. Br J Haematol. 2002. PMID: 12406066 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

186 results

Search Page

Filters